Advertisement
Screener

Orthofix Medical Inc. (OFIX) Amortization of Intangible Assets

2.8 / 5 stars · 68/120 Roast Me

Orthofix Medical Inc. Amortization of Intangible Assets

Orthofix Medical Inc. (OFIX) reported Amortization of Intangible Assets of $30.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-24.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:AmortizationOfIntangibleAssets · last filed 2026-02-24

  • Orthofix Medical Inc. amortization of intangible assets for the quarter ending 2019-12-31 was $3.27M, a 72.13% increase year-over-year.
  • Orthofix Medical Inc. amortization of intangible assets for the quarter ending 2019-09-30 was $1.34M, a 211.89% increase year-over-year.
  • Orthofix Medical Inc. amortization of intangible assets for the quarter ending 2019-06-30 was $1.34M, a 331.61% increase year-over-year.
  • Orthofix Medical Inc. amortization of intangible assets for the quarter ending 2019-03-31 was $1.06M, a 1577.78% increase year-over-year.
  • Orthofix Medical Inc. amortization of intangible assets for fiscal 2025 was $30.00M, a 57.89% increase from fiscal 2024.
  • Orthofix Medical Inc. amortization of intangible assets for fiscal 2024 was $19.00M, a 0.53% increase from fiscal 2023.
  • Orthofix Medical Inc. amortization of intangible assets for fiscal 2023 was $18.90M, a 101.06% increase from fiscal 2022.
  • Orthofix Medical Inc. amortization of intangible assets for fiscal 2022 was $9.40M, a 0.00% change from fiscal 2021.
Period endAmortization of Intangible Assets 3 monthAmortization of Intangible Assets 3 month as first filedAmortization of Intangible Assets 6 monthAmortization of Intangible Assets 6 month as first filedAmortization of Intangible Assets 9 monthAmortization of Intangible Assets 9 month as first filedAmortization of Intangible Assets 12 monthAmortization of Intangible Assets 12 month as first filed
2025-12-31$30.00M
10-K · filed 2026-02-24
2024-12-31$19.00M
10-K · filed 2026-02-24
2023-12-31$18.90M
10-K · filed 2026-02-24
2022-12-31$9.40M
10-K · filed 2025-02-25
2021-12-31$9.40M
10-K · filed 2024-03-05
2020-12-31$11.20M
10-K · filed 2023-03-06
2019-12-31$3.27M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25
$4.61M
derived: sum of 2 quarters · filed 2022-02-25
$5.94M
derived: sum of 3 quarters · filed 2022-02-25
$7.00M
10-K · filed 2022-02-25
2019-09-30$1.34M
10-Q · filed 2019-10-28
$2.68M
derived: sum of 2 quarters · filed 2019-10-28
$3.73M
10-Q · filed 2019-10-28
$5.63M
derived: sum of 4 quarters · filed 2021-02-26
2019-06-30$1.34M
10-Q · filed 2019-08-05
$2.40M
10-Q · filed 2019-08-05
$4.29M
derived: sum of 3 quarters · filed 2021-02-26
$4.72M
derived: sum of 4 quarters · filed 2021-02-26
2019-03-31$1.06M
10-Q · filed 2019-05-06
$2.96M
derived: sum of 2 quarters · filed 2021-02-26
$3.38M
derived: sum of 3 quarters · filed 2021-02-26
$3.69M
derived: sum of 4 quarters · filed 2021-02-26
2018-12-31$1.90M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26
$2.33M
derived: sum of 2 quarters · filed 2021-02-26
$2.64M
derived: sum of 3 quarters · filed 2021-02-26
$2.70M
10-K · filed 2021-02-26
2018-09-30$429.00K
10-Q · filed 2019-10-28
$739.00K
derived: sum of 2 quarters · filed 2019-10-28
$802.00K
10-Q · filed 2019-10-28
2018-06-30$310.00K
10-Q · filed 2019-08-05
$373.00K
10-Q · filed 2019-08-05
2018-03-31$63.00K
10-Q · filed 2019-05-06
2017-12-31$1.80M
10-K · filed 2020-02-24
2016-12-31$1.80M
10-K · filed 2019-02-25
2015-12-31$1.70M
10-K · filed 2018-02-26
2015-03-31$405.00K
10-Q · filed 2015-05-18
$952.00K
derived: sum of 2 quarters · filed 2017-02-27
$1.46M
derived: sum of 3 quarters · filed 2017-02-27
$2.12M
derived: sum of 4 quarters · filed 2017-02-27
2014-12-31$547.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27
$1.05M
derived: sum of 2 quarters · filed 2017-02-27
$1.72M
derived: sum of 3 quarters · filed 2017-02-27
$2.30M
10-K · filed 2017-02-27
$2.28M
10-K · filed 2015-04-29
2014-09-30$508.00K
10-Q · filed 2015-03-31
$1.17M
derived: sum of 2 quarters · filed 2015-03-31
$1.75M
10-Q · filed 2015-03-31
$2.73M
derived: sum of 4 quarters · filed 2016-02-29
2014-06-30$661.00K
10-Q · filed 2015-03-31
$1.25M
10-Q · filed 2015-03-31
$2.22M
derived: sum of 3 quarters · filed 2016-02-29
$2.84M
derived: sum of 4 quarters · filed 2016-02-29
2014-03-31$584.00K
10-Q · filed 2015-05-18
$1.56M
derived: sum of 2 quarters · filed 2016-02-29
$2.17M
derived: sum of 3 quarters · filed 2016-02-29
$2.74M
derived: sum of 4 quarters · filed 2016-02-29
2013-12-31$975.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29
$1.59M
derived: sum of 2 quarters · filed 2016-02-29
$2.16M
derived: sum of 3 quarters · filed 2016-02-29
$2.70M
10-K · filed 2016-02-29
$2.69M
10-K · filed 2014-03-31
2013-09-30$616.00K
10-Q · filed 2015-03-31
$1.18M
derived: sum of 2 quarters · filed 2015-03-31
$1.73M
10-Q · filed 2015-03-31
$2.30M
derived: sum of 4 quarters · filed 2015-04-29
2013-06-30$565.00K
10-Q · filed 2015-03-31
$1.11M
10-Q · filed 2015-03-31
$1.68M
derived: sum of 3 quarters · filed 2015-04-29
$2.25M
derived: sum of 4 quarters · filed 2015-04-29
2013-03-31$544.00K
10-Q/A · filed 2015-03-31
$504.00K
10-Q · filed 2013-05-09
$1.12M
derived: sum of 2 quarters · filed 2015-04-29
$1.68M
derived: sum of 3 quarters · filed 2015-04-29
$2.26M
derived: sum of 4 quarters · filed 2015-04-29
2012-12-31$573.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-04-29
$1.14M
derived: sum of 2 quarters · filed 2015-04-29
$1.72M
derived: sum of 3 quarters · filed 2015-04-29
$2.30M
10-K · filed 2015-04-29
$2.10M
10-K · filed 2013-03-01
2012-09-30$565.00K
10-Q · filed 2014-03-25
$515.00K
10-Q · filed 2012-11-02
$1.15M
derived: sum of 2 quarters · filed 2014-03-25
$1.73M
10-Q · filed 2014-03-25
$1.57M
10-Q · filed 2012-11-02
$2.63M
derived: sum of 4 quarters · filed 2015-03-31
2012-06-30$580.00K
10-Q · filed 2014-03-24
$530.00K
10-Q · filed 2012-07-30
$1.16M
10-Q · filed 2014-03-24
$1.06M
10-Q · filed 2012-07-30
$2.07M
derived: sum of 3 quarters · filed 2015-03-31
$2.61M
derived: sum of 4 quarters · filed 2015-03-31
2012-03-31$580.00K
10-Q/A · filed 2014-03-24
$1.25M
10-Q · filed 2012-05-04
$1.49M
derived: sum of 2 quarters · filed 2015-03-31
$2.03M
derived: sum of 3 quarters · filed 2015-03-31
$2.58M
derived: sum of 4 quarters · filed 2015-03-31
2011-12-31$909.00K
derived: 10-K/A 12 month − 10-Q 9 month · filed 2015-03-31
$1.45M
derived: sum of 2 quarters · filed 2015-03-31
$2.00M
derived: sum of 3 quarters · filed 2015-03-31
$2.55M
10-K/A · filed 2015-03-31
$5.59M
10-K · filed 2012-02-29
2011-09-30$537.00K
10-Q · filed 2012-11-02
$1.32M
10-Q · filed 2011-10-31
$1.09M
derived: sum of 2 quarters · filed 2012-11-02
$1.64M
10-Q · filed 2012-11-02
$3.95M
10-Q · filed 2011-10-31
$501.00K
derived: sum of 4 quarters · filed 2014-03-24
2011-06-30$555.00K
10-Q · filed 2012-07-30
$1.37M
10-Q · filed 2011-08-05
$1.10M
10-Q · filed 2012-07-30
$2.63M
10-Q · filed 2011-08-05
-$36.00K
derived: sum of 3 quarters · filed 2014-03-24
$1.37M
derived: sum of 4 quarters · filed 2014-03-24
2011-03-31$1.25M
10-Q · filed 2012-05-04
-$591.00K
derived: sum of 2 quarters · filed 2014-03-24
$811.00K
derived: sum of 3 quarters · filed 2014-03-24
$2.22M
derived: sum of 4 quarters · filed 2014-03-24
2010-12-31-$1.85M
derived: 10-K/A 12 month − 10-Q 9 month · filed 2014-03-24
-$444.00K
derived: sum of 2 quarters · filed 2014-03-24
$966.00K
derived: sum of 3 quarters · filed 2014-03-24
$2.41M
10-K/A · filed 2014-03-24
$5.76M
10-K · filed 2012-02-29
2010-09-30$1.40M
10-Q · filed 2011-10-31
$2.81M
derived: sum of 2 quarters · filed 2011-10-31
$4.26M
10-Q · filed 2011-10-31
2010-06-30$1.41M
10-Q · filed 2011-08-05
$2.86M
10-Q · filed 2011-08-05
2009-12-31$7.04M
10-K · filed 2012-02-29

Similar stocks

Stock NameCountryMarket CapPE Ratio
Orchestra BioMed Holdings, Inc. (OBIO)United States$0.356B-4.39
SHOULDER INNOVATIONS, INC. (SI)United States$0.355B
CARLSMED, INC. (CARL)United States$0.405B
Embecta Corp. (EMBC)United States$0.319B2.10
ClearPoint Neuro, Inc. (CLPT)United States$0.446B-15.74
TREACE MEDICAL CONCEPTS, INC. (TMCI)United States$0.297B-4.32
Mobia Medical, Inc. (MOBI)United States$0.293B
TriSalus Life Sciences, Inc. (TLSI)United States$0.283B-9.92
Cytosorbents Corp (CTSO)United States$0.274B-1.29
ORASURE TECHNOLOGIES INC (OSUR)United States$0.272B-6.26